KAYLEE LEE: Open Payments
NPI 1215590138 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 147 payments from 21 companies in 2025. Trend: 2023 $788 · 2024 $3,066 · 2025 $2,753
Food & beverage: $2,653Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 21 | $477 |
| Regeneron Healthcare Solutions, Inc. | 19 | $415 |
| Janssen Biotech, Inc. | 20 | $389 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $263 |
| ABBVIE INC. | 18 | $209 |
| Novartis Pharmaceuticals Corporation | 10 | $172 |
| UCB, Inc. | 9 | $171 |
| Incyte Corporation | 8 | $161 |
| Arcutis Biotherapeutics, Inc. | 5 | $96 |
| Organon LLC | 7 | $92 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, OPZELURA, Winlevi, COSENTYX.
Industry payments across AZ — which companies pay providers there.
